TABLE 3.
Control group |
PD patient group |
|||||||
ST |
DT |
ST |
DT |
|||||
OE | CE | OE | CE | OE | CE | OE | CE | |
Trace length (mm) | 1433.42 ± 311.66 | 1535.72 ± 270.34 | 1460.89 ± 309.23 | 1570.06 ± 334.99 | 1484.12 ± 316.47 | 1704.42 ± 407.54 | 1519.86 ± 424.89 | 1727.27 ± 577.12 |
Area (mm2) | 1958.87 ± 626.61 | 2291.25 ± 1110.07 | 1821.46 ± 825.60 | 2007.67 ± 1136.01 | 3030.70 ± 1254.25 | 4011.22 ± 1637.79 | 2683.34 ± 979.07 | 3473.88 ± 1371.51 |
Radius (mm) | 4.81 ± 1.67 | 5.24 ± 1.98 | 4.34 ± 4.31 | 4.31 ± 1.45 | 6.75 ± 2.35 | 7.69 ± 1.95 | 5.78 ± 1.38 | 6.43 ± 1.33 |
A-P sway (mm) | 40.49 ± 26.89 | 46.08 ± 24.61 | 44.88 ± 28.65 | 40.86 ± 30.90 | 69.28 ± 31.48 | 67.49 ± 31.29 | 64.06 ± 35.65 | 63.26 ± 24.22 |
M-L sway (mm) | 6.85 ± 4.91 | 5.74 ± 4.67 | 4.49 ± 4.69 | 4.60 ± 3.90 | 6.05 ± 4.47 | 6.60 ± 5.31 | 7.35 ± 3.85 | 6.47 ± 4.33 |
A-P range (mm) | 22.81 ± 7.55 | 28.78 ± 9.90 | 21.67 ± 8.58 | 23.43 ± 7.94 | 31.32 ± 13.25 | 36.98 ± 9.46 | 27.43 ± 8.38 | 31.77 ± 8.69 |
M-L range (mm) | 15.71 ± 5.42 | 17.41 ± 8.51 | 14.20 ± 5.76 | 15.62 ± 7.33 | 23.74 ± 7.25 | 29.81 ± 9.12 | 21.44 ± 5.26 | 28.05 ± 9.12 |
Values are Mean ± Standard Deviation. PD, Parkinson’s disease; ST, single task; DT, dual-task; OE, open eyes; CE, closed eyes; A-P, anteroposterior; M-L, mediolateral.